Filing Details

Accession Number:
0000950170-25-044469
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-25 16:39:57
Reporting Period:
2025-03-21
Filing Date:
2025-03-25
Accepted Time:
2025-03-25 16:39:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1713863 Rafael Holdings Inc. RFL Pharmaceutical Preparations (2834) 822296593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1852018 William Conkling C/O Rafael Holdings, Inc.
520 Broad St
Newark NJ 07102
Chief Executive Officer No No No No
Transaction Summary
Number of Shares After Transactions: 537,001 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock, Par Value $.01 Per Share Disposition 2025-03-21 14,814 $1.93 537,001 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
Footnotes
  1. Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock.
  2. Consists of 146,955 shares of stock held directly, 183,094 fully vested shares of Restricted Stock and 206,952 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2025 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027; and 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029.